QT
MEDP icon

Quantbot Technologies’s Medpace MEDP Stock Holding History

Quantbot Technologies’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Sell
1,297
-7,799
-86% -$3.6M 0.03% 788
2026
Q1 		$4.37M Sell
9,096
-6,263
-41% -$3.21M 0.18% 149
2025
Q4 		$8.63M Sell
15,359
-853
-5% -$484K 0.29% 61
2025
Q3 		$8.34M Sell
16,212
-17,963
-53% -$7.84M 0.23% 93
2025
Q2 		$10.7M Buy
34,175
+31,636
+1,246% +$9.5M 0.28% 77
2025
Q1 		$774K Sell
2,539
-1,789
-41% -$602K 0.02% 758
2024
Q4 		$1.44M Sell
4,328
-8,276
-66% -$2.81M 0.05% 515
2024
Q3 		$4.21M Buy
12,604
+5,892
+88% +$2.24M 0.17% 167
2024
Q2 		$2.76M Buy
6,712
+4,397
+190% +$1.74M 0.13% 236
2024
Q1 		$936K Sell
2,315
-193
-8% -$67.9K 0.05% 533
2023
Q4 		$769K Sell
2,508
-4,359
-63% -$1.18M 0.04% 568
2023
Q3 		$1.66M Sell
6,867
-3,984
-37% -$1.02M 0.11% 270
2023
Q2 		$2.61M Sell
10,851
-5,211
-32% -$1.08M 0.17% 173
2023
Q1 		$3.02M Buy
16,062
+11,592
+259% +$2.4M 0.21% 128
2022
Q4 		$949K Buy
4,470
+2,606
+140% +$521K 0.07% 387
2022
Q3 		$292K Buy
+1,864
New +$297K 0.02% 765
2022
Q1 		– Sell
-6,477
Closed -$1.41M – 1892
2021
Q4 		$1.41M Buy
6,477
+396
+7% +$82.9K 0.11% 268
2021
Q3 		$1.15M Buy
+6,081
New +$1.11M 0.08% 346
2021
Q2 		– Sell
-4,486
Closed -$735K – 1701
2021
Q1 		$735K Buy
+4,486
New +$686K 0.07% 368
2020
Q4 		– Sell
-5,457
Closed -$609K – 1520
2020
Q3 		$609K Buy
5,457
+5,361
+5,584% +$620K 0.07% 307
2020
Q2 		$8K Buy
+96
New +$8.17K ﹤0.01% 952
2019
Q4 		– Sell
-163
Closed -$13K – 1453
2019
Q3 		$13K Buy
+163
New +$12.3K ﹤0.01% 1152
2018
Q4 		– Sell
-14,265
Closed -$854K – 1246
2018
Q3 		$854K Buy
+14,265
New +$780K 0.06% 416
2018
Q1 		– Sell
-90
Closed -$3K – 1388
2017
Q4 		$3K Buy
+90
New +$3.15K ﹤0.01% 1139

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Quantbot Technologies's MEDP Position: Q2 2026 in Review

Quantbot Technologies reduced its Medpace (MEDP) stake by 86% in Q2 2026, selling an estimated $3.6M and leaving 1,297 shares worth $687K. The position accounts for 0.03% of the portfolio, ranked #788.

Quantbot Technologies first reported a position in MEDP in Q4 2017 and has held it in 24 quarters since. The position peaked at $10.7M in Q2 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Quantbot Technologies held 1,297 shares of Medpace worth $687K as of Q2 2026.
  • Quantbot Technologies sold 7,799 Medpace shares in Q2 2026, an estimated $3.6M.
  • Medpace made up 0.03% of Quantbot Technologies's portfolio in Q2 2026, its #788 holding.
  • Quantbot Technologies first reported a position in Medpace in Q4 2017 and has held it in 24 quarters since.
  • Quantbot Technologies's Medpace position peaked at $10.7M in Q2 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.